Scavenger receptor B-I antagonist ITX5061 modulates early HCV kinetics in patients undergoing liver transplantation: results of a phase Ib clinical trial

Rowe IA., Armstrong MJ., Parker R., Guo K., Barton D., Morse GD., McKelvy J., Wong-Staal F., Adams DH., McKeating JA., Mutimer DJ.

Type

Conference paper

Publication Date

2013-01-01T00:00:00+00:00

Volume

58

Pages

239A - 239A

Permalink Close